Detalhe da pesquisa
1.
Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial.
Mov Disord
; 37(3): 513-524, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34859493
2.
Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.
Alzheimers Dement
; 16(8): 1134-1145, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573913
3.
Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
Headache
; 58(10): 1689-1696, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30426478
4.
Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons.
BMC Genet
; 17: 16, 2016 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26738766
5.
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.
Alzheimers Dement
; 11(7): 792-814, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26194313
6.
Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain.
Mol Pain
; 10: 37, 2014 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24934217
7.
Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets.
Neuroepidemiology
; 43(3-4): 194-205, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25402421
8.
Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease.
Neurology
; 102(5): e208061, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38386949
9.
Wrist-worn sensor-based measurements for drug effect detection with small samples in people with Lewy Body Dementia.
Parkinsonism Relat Disord
; 109: 105355, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905719
10.
Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia.
Digit Biomark
; 7(1): 54-62, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404864
11.
Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia.
J Parkinsons Dis
; 12(6): 1991-2004, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35694933
12.
Characteristics of Parkinson's Disease in Patients with and without Cognitive Impairment.
J Parkinsons Dis
; 11(3): 1381-1392, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720850
13.
Lewy Body Dementia Association's Industry Advisory Council: proceedings of the second annual meeting.
Alzheimers Res Ther
; 13(1): 124, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34238345
14.
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.
Alzheimers Res Ther
; 12(1): 137, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121510
15.
One-Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort Study.
J Am Geriatr Soc
; 66(5): 969-975, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29608782
16.
Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia.
J Pers Med
; 6(1)2016 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26861400
17.
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers.
Brain Imaging Behav
; 8(2): 183-207, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24092460
18.
Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex.
Biol Psychiatry
; 73(6): 546-54, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23158458